Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

553

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

August 18, 2023

Study Completion Date

August 18, 2023

Conditions
Transthyretin Cardiac Amyloidosis
Interventions
PROCEDURE

Bony scintigraphy

Bony scintigraphy (99mTc-Hydromethylene diphosphonate) will be performed in all patients with hypertrophy of the left ventricle

Trial Locations (1)

86000

C.H.U. de Poitiers, Poitiers

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Poitiers University Hospital

OTHER